Zhejiang Haisen Pharmaceutical Co., Ltd. (001367.SZ)

23.34 +0.26 (+1.13%) At close: 03:04PM CST

Zhejiang Haisen Pharmaceutical Co., Ltd.

Liushi Street
Xiangtan Village
Dongyang 322104
China
86 579 8676 8756
https://www.haisenpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full-time employees: 636

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Lin Ai	GM & Director	N/A	N/A	1961

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China. The company offers APIs for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, antibacterial agent, antipyretic analgesics, histamines drug, and anticonvulsant. It also provides chemical product for intermediates and food additives. Zhejiang Haisen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Dongyang, China.

Corporate governance

Zhejiang Haisen Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.